Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Felix B who wrote (2777)	10/31/2019 10:17:52 PM
From: Miljenko Zuanic	Respond to of 3557

I do not know about surprise and move the stock, but I do think that US-Eylea sale of >$1200M (or just maybe $1180M) will be seen as positive for future. Also, bit metrics and comments on competitor lunch, how is seen from REGN perspective. Something from pipeline may be more of near-term importance, than current sale numbers.

To: Felix B who wrote (2777)	11/5/2019 10:01:35 AM
From: Miljenko Zuanic	Respond to of 3557

<Something from pipeline may be more of near-term importance, than current sale numbers.> More or Less, this is what I had in mind, IO update, (but, there is also other platform programs that will surface.....from RGC) : investor.regeneron.com